Skip to main content
In stock|Targeted Therapy

Imetelstat

Oncology TypeHematologic (MDS)
Drug Class / MechanismOligonucleotide Telomerase Inhibitor (first-in-class)
No Image
Description

Imetelstat is classified as an Oligonucleotide Telomerase Inhibitor (first-in-class), sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy
Oncology TypeHematologic (MDS)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3